Pre-Conference Symposia – International Stroke Conference
ISC Sessions: February 7–9, 2024
Phoenix Convention Center | Phoenix, Arizona
A Full Day of Learning Tailored to You
Our popular Pre-Con Symposia are back once again in 2025! All three of these programs are designed to help you deliver the best stroke science to your patients.
- HEADS-UP - Health Equity and Actionable Disparities in Stroke: Understanding and Problem-Solving
- Fast And Furious: Stroke in the Real World - Addressing Challenges in Acute Stroke Managment
- Stroke in the Lab World - the latest in stroke and brain health discoveries at the cellular level.
Scroll down to see the programming; more detail will be added as the program is confirmed.
Pre-Con Symposia Schedules
2025 HEADS-UP: Health Equity and Actionable Disparities in Stroke: Understanding and Problem Solving
Tuesday, February 4, 2025
8:30 a.m. to 5:30 p.m. (PST)
A separate registration is required to attend the Pre-Conference Symposia.
This symposium is a multidisciplinary scientific forum focused on race-ethnic disparities in cerebrovascular disease, with the overarching goal of reducing disparities in stroke and accelerating translation of research findings to improve outcomes for race-ethnic minorities who reside in the US. HEADS-UP is a collaborative initiative with the American Stroke Association (ASA), a national organization "dedicated to advancing the science of stroke prevention, treatment and recovery through research and education", and the National Institutes for Neurological Disorders and Stroke (NINDS). In addition to exciting lectures being given by leaders in this field, twenty early career scholars will present their disparities research work at a dedicated poster session as well as participate in career development sessions. A plenary lecture in honor of the late Edgar Kenton, MD will be given by an outstanding researcher selected by the HEADS-UP Program Committee, with a solid track record of studying or addressing stroke disparities.
Time | Activity |
---|---|
8:30 a.m. to 9:00 a.m. |
8:30 a.m. Welcome, Pre-test, Policy Maker Introduction 8:55 a.m. Q&A |
9:00 a.m. to 10:00 a.m. | Session 1: SDOH Determinants (Epi side) - Perspective of NINDS Framework 9:00 a.m. Overview of NINDS Framework: EPI Perspective on Social Determinants 9:05 a.m. Presentation 1: Lived Experience 9:20 a.m. Presentation 2: What Is Known 9:35 a.m. Panel Discussion |
10:00 a.m. to 10:15 a.m. | Break |
10:15 to 10:45 a.m. |
10:15 a.m. Introduction of the Edgar J. Kenton III Lecture |
10:45 a.m. |
Think Tanks on Works in Progress (Career Development Session) |
12:00 p.m. to 1:00 p.m. | Lunch |
1:00 p.m. to 1:15 p.m. |
Introduction to the NINDS Speaker |
1:15 p.m. to 3:15 p.m. | HEADS-UP Poster Session See ISC 2025 Online Program Planner for a complete list of poster abstracts. |
3:15 p.m. to 3:30 p.m. | Break |
3:30 p.m. to 4:30 p.m. |
Session 2: Interventions (CBPR, Clinical Engagement, Policy) |
4:30 p.m. to 5:30 p.m. |
Building Momentum (Career Development Session) |
5:30 p.m. | Closing Remarks, Post-Test & Adjourn Amytis Towfighi |
2025 Fast and Furious: Stroke in the Real World - Addressing Challenges In Acute Stroke Management
Tuesday, February 4, 2025
8:30 a.m. to 5:00 p.m.
A separate registration is required to attend the Pre-Conference Symposia.
This Pre-Conference Symposium of the International Stroke Conference is designed to provide cutting edge information for healthcare professionals caring for patients with, or at risk for stroke. This one-day symposium highlights scientific advances in cerebrovascular disease while emphasizing their application in the real world. The symposium informs the audience about issues along the full continuum of stroke care and covers varied topics of interest to healthcare providers working in the emergency department, hospitalist settings, primary care, general neurology, pharmacies, and other stroke care arenas. This year’s symposium will focus on addressing challenges in acute stroke management.
Time | Activity |
---|---|
8:30 a.m. to 8:35 a.m. | Welcome Mollie McDermott |
8:35 a.m. to 9:15 a.m. | M*A*S*H: Moving Care to the Field 8:35 a.m. Debate: Mobile Stroke Units Are Ready For Prime Time, And You Are Failing Your Patients If You Are Not Using Them James C. Grotta 8:45 a.m. Debate: Mobile Stroke Units Are Impractical, Expensive, And Not Ready for Widespread Use Babak Navi 9:00 a.m. Panel Discussion |
9:15 a.m. to 10:15 a.m. | Under Pressure: How to Treat Blood Pressure in the Ambulance and the ED Moderator: Natalie Kreitzer 9:15 a.m. Stroke Symptoms in the Ambulance Gang Li 9:30 a.m. Ischemic Stroke: Before Revascularization Kara Melmed 9:45 a.m. Hemorrhagic Stroke: What is the Goal and How Fast to Get There? 10:00 a.m. Panel Discussion |
10:15 a.m. to 10:30 a.m. | Break |
10:30 a.m. to 11:30 a.m. |
You Spin Me Round: Which Patients with Acute Onset “Dizziness” Should We Call A Code Stroke For? Case Discussions |
11:30 a.m. to 12:30 p.m. | First Blood: Time is Brain in ICH Too! Moderator: Kara Melmed 11:30 a.m. Should There be a Goal Time to BP Treatment? Aleksandra Yakhkind 11:45 a.m. Should There be a Goal Time for Anticoagulation Reversal? 12:00 p.m. Should There Be a Goal Time to Surgical Evaluation? Gustavo Pradilla 12:15 p.m. Panel Discussion |
12:30 p.m. to 1:30 p.m. | Lunch |
1:30 p.m. to 2:30 p.m. |
Wild Wild West: Frontiers of EVT - Large Core, Mild and Distal Occlusions
Mayank Goyal |
2:30 p.m. to 4:00 p.m. | Frontiers in IVT 2:30 Summary of Tenecteplase data 0-24h Yunyun Xiong 2:45 Debate: IVT Beyond 4.5h Should be Implemented in Primary Stroke Centers 2:55 Debate: IVT beyond 4.5h Should Not Be Implemented in Primary Stroke Negar Asdaghi 3:05 Everything but the Kitchen Sink: IVT when patients are destined for EVT (0-4.5 and >4.5h) - What to Use And When? 3:20 Case-Based Session - Imaging Interpretation and Decision-Making with all Speakers from Above Bruce C. Campbell |
4:00 p.m. to 4:30 p.m. | Surgical Management of ICH: Implications of the Enrich Results in Clinical Practice 4:20 Q&A |
4:30 p.m. to 5:00 p.m. | Debate: 4:30 Pro: Andexanet alfa is Preferred over PCC for Reversal of FXa Inhibitor Associated ICH Ashkan Shoamanesh 4:40 Con: Andexanet alfa is Preferred over PCC for Reversal of FXa Inhibitor Associated ICH Shadi Yaghi 4:50 Q&A |
5:00 p.m. | Closing Remarks Theodore Wein |
2025 Stroke in the Lab World: Investigational Targets in Ischemic Stroke: Ready, Set, Translate!
Tuesday, February 4, 2025
9:00 a.m. to 5:00 p.m.
A separate registration is required to attend the Pre-Conference Symposia.
Investigational Targets in Ischemic Stroke: Ready, Set, Translate!
After the success of last year’s Stroke in the Lab World focusing on Multicenter Preclinical Trials, this year we are planning an all-day symposium putting the spotlight on a broad range of promising investigational targets in stroke therapy. We will cover pharmacological, physiological, and device interventions. Each speaker will take up a particular class of interventions or targets and provide a systematic unbiased overview of the strengths and weaknesses of the data available, putting it under the lens for readiness for a multicenter preclinical trial and eventual clinical translation.
Each session will start with a poll on which target in that session is the most promising and end with a repeat poll of the same. Each session will also include generous time for a forum with audience participation. At the end of the symposium, we will poll the audience for their top three targets.
We hope the program will stimulate broad interest, not only to see what others think about the targets they are interested in, but also to educate themselves about other promising targets out there. With audience engagement, we will parse through targets that may be considered old pickles and others that may be controversial.
Time | Activity |
---|---|
9:00 a.m. to 10:30 a.m. | 9:00 Welcome 9:05 Introduction Sarah McCann 9:30 Cells and Extracellular Vesicles - I 9:55 Cells and Extracellular Vesicles - II Devika S Manickam 10:20 Q&A |
10:35 a.m. to 10:50 a.m. | Break |
10:50 a.m. to 12:15 p.m. | 10:50 Growth and Transcription Factors 11:15 Hormones Farida Sohrabji 11:40 Antioxidants Thomas Kent 12:05 Q&A |
12:20 p.m. to 1:20 p.m. | Lunch |
1:20 p.m. to 2:50 p.m. | 1:20 Neuromodulation Ethem Arsava 1:45 Immunomodulation - I 2:10 Immunomodulation - II Che-Feng Chang 2:35 Q&A |
2:50 p.m. to 3:05 p.m. | Break |
3:05 p.m. to 4:55 p.m. | 3:05 Hypothermia Patrick Lyden 3:30 Normobaric Hyperoxia 3:55 Glutamate Receptors Alastair Buchan 4:20 Q&A |
4:35 p.m. to 4:50 p.m. | Perspectives from a Clinical Trialist Bijoy Menon |
4:50 p.m. | Closing Remarks |